The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery

NCT01432652 | Completed

• 1 other identifier: 176/11
• Study Type: observational
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to determine the incidence of aspirin resistance in the population of vascular surgery patients; and to evaluate the changes in the efficacy of aspirin in the first five postoperative days.

Conditions

Aspirin Resistance

Study Arms (1)

vascular surgery

Patients undergoing vascular surgery

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Vascular surgery patients

You may qualify if:

• Patient undergoing peripheral vascular or abdominal aorta surgery.
• Patient aged 18 years or older.
• Patient treated by aspirin.

You may not qualify if:

• Incapacity to understand and consent to study.
• Patient undergoing emergency surgery.
• Patient treated by a cox-inhibitor other than aspirin.
• Patient treated by omega-3-fatty acids.
• Patient treated by ADP or GPIIb/IIIa receptor inhibitor.
• Known coagulopathy, thrombopenia, thrombopathia or congenital or acquired thrombasthenia.
• Terminal renal insufficiency.
• Hepathic insufficiency.

Sponsors & Collaborators

• University of Lausanne Hospitals: lead

Study Sites (1)

University of Lausanne Hospitals

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: September 12, 2011
• First Posted: September 13, 2011
• Study Start: September 1, 2011
• Primary Completion: January 1, 2014
• Study Completion: May 1, 2014
• Last Updated: July 29, 2015

Record last verified: 2011-09

Locations

CH (1)